📰 Nasdaq Prtg News
Nasdaq Prtg News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Prtg. Real-time updates on events, politics, business and more.
April 12, 2024
Portage Biotech Inc. (NASDAQ:PRTG – Get Free Report) was the recipient of a significant decrease in short interest during the month of March. As of March 31st, there was short interest totalling 6,500 shares, a decrease of 57.8% from the March 15th total of 15,400 shares. Based on an average daily trading volume, of 59,500 […]
January 30, 2024
Portage Biotech Inc. (NASDAQ:PRTG – Get Free Report) saw a significant growth in short interest in January. As of January 15th, there was short interest totalling 7,600 shares, a growth of 16.9% from the December 31st total of 6,500 shares. Based on an average trading volume of 34,100 shares, the days-to-cover ratio is currently 0.2 […]
January 12, 2024
HC Wainwright downgraded shares of Portage Biotech (NASDAQ:PRTG – Free Report) from a buy rating to a neutral rating in a report issued on Monday morning, Marketbeat.com reports. Portage Biotech Stock Performance Portage Biotech stock opened at $1.08 on Monday. The company has a 50 day moving average price of $1.39 and a 200-day moving […]
January 1, 2024
Portage Biotech Inc. (NASDAQ:PRTG – Get Free Report) was the recipient of a large decline in short interest in December. As of December 15th, there was short interest totalling 17,600 shares, a decline of 25.4% from the November 30th total of 23,600 shares. Based on an average trading volume of 32,800 shares, the short-interest ratio […]
September 11, 2023
Cantor Fitzgerald reissued their overweight rating on shares of Portage Biotech (NASDAQ:PRTG – Free Report) in a research note released on Thursday morning, Benzinga reports. They currently have a $11.00 target price on the stock. Separately, HC Wainwright lowered their target price on shares of Portage Biotech from $21.00 to $9.00 and set a buy […]
September 1, 2023
Portage Biotech (NASDAQ:PRTG – Get Free Report) announced its earnings results on Wednesday. The company reported ($0.33) EPS for the quarter, missing analysts’ consensus estimates of ($0.24) by ($0.09), MarketWatch Earnings reports. Portage Biotech Stock Performance NASDAQ:PRTG opened at $2.56 on Friday. Portage Biotech has a one year low of $2.30 and a one year […]
September 1, 2023
Portage Biotech (NASDAQ:PRTG – Get Free Report) posted its quarterly earnings data on Wednesday. The company reported ($0.33) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.24) by ($0.09), MarketWatch Earnings reports. Portage Biotech Price Performance Portage Biotech stock traded down $0.01 during mid-day trading on Friday, reaching $2.55. The stock […]
August 23, 2023
Portage Biotech (NASDAQ:PRTG – Get Free Report) and VOC Energy Trust (NYSE:VOC – Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, profitability, institutional ownership, valuation and earnings. Insider & Institutional Ownership 1.0% of Portage […]
August 4, 2023
Portage Biotech Inc. (NASDAQ:PRTG – Free Report) – Stock analysts at HC Wainwright raised their Q1 2024 EPS estimates for shares of Portage Biotech in a research report issued on Wednesday, August 2nd. HC Wainwright analyst R. Burns now expects that the company will post earnings per share of ($0.25) for the quarter, up from […]
August 4, 2023
Portage Biotech Inc. (NASDAQ:PRTG – Free Report) – Research analysts at Cantor Fitzgerald increased their FY2024 earnings estimates for Portage Biotech in a research note issued on Tuesday, August 1st. Cantor Fitzgerald analyst L. Watsek now forecasts that the company will earn ($0.67) per share for the year, up from their previous forecast of ($0.93). […]